drugset / Trial / NCT00918047
Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Study to evaluate the pharmacokinetics, safety, and tolerability of OXC XR as adjunctive therapy in pediatric subjects with refractory partial epilepsy.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-07
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPN-804O | Unknown | 150 mg | — |
| Subject | SPN-804O | Unknown | 300 mg | — |
| Subject | SPN-804O | Unknown | 450 mg | — |
| Subject | SPN-804O | Unknown | 600 mg | — |